NR3C1 is required for normal somatotrope differentiation and Foxo1 expression in pituitary
Endocrinology · 26.05.2026 · 167 (7)
DOI: 10.1210/endocr/bqag060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, online erschienen am 16.05.2026. Verfasst von Pratyusa Das und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular and Integrative Physiology, Southern Illinois University School of Medicine, Carbondale, IL 62901-6523, USA. Hauptthemen laut MEDLINE: Forkhead Box Protein O1, Cell Differentiation, Somatotrophs, Receptors, Glucocorticoid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NICHD NIH HHS, National Institute of Child Health and Human Development, Francis Crick Institute.
Abstract (Originalsprache)
Glucocorticoids are an important signal for the differentiation of many types of cells. Consistent with this, several studies have demonstrated that glucocorticoids promote the somatotrope differentiation program and functionality. Interestingly, we previously found that loss of the forkhead factor, FOXO1, results in delayed emergence of somatotropes and prevents glucocorticoid-induced premature differentiation of somatotropes. In the present study, we find that pituitary-specific deletion of Nr3c1, the gene encoding the glucocorticoid receptor, impairs somatotrope differentiation and increases lactotrope numbers embryonically and at 5 days after birth. The number of somatotropes remains reduced at age 7 weeks in females and males, but lactotrope cell numbers are increased only in females at this age. FOXO1 is nearly undetectable in pituitary glands from mouse embryos lacking NR3C1 and continues to be reduced in adults. These findings suggest that glucocorticoids are an important signal for determining the balance between somatotropes and lactotropes and that FOXO1 may mediate NR3C1 induction of somatotrope differentiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Molecular and Integrative Physiology, Southern Illinois University School of Medicine, Carbondale, IL 62901-6523, USA.
- Department of Human Genetics, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
- Genetic Modification Service, The Francis Crick Institute, London NW1 1AT, UK.
- Laboratory of Stem Cell Biology and Developmental Genetics, Francis Crick Institute, London NW1 1AT, UK.
ORCID-Profile: Pratyusa Das, Ridwanullah A Abubakar, Nooshin Mojahed, Michelle L Brinkmeier, Jessica Olsen, Sally A Camper, Robin Lovell-Badge, Karine Rizzoti, Buffy S Ellsworth
Förderung
- NICHD NIH HHS
- National Institute of Child Health and Human Development
- Francis Crick Institute
- Wellcome Trust
- Cancer Research UK
- UK Medical Research Council
Zitieren
APA
Das, P., Abubakar, R. A., Mojahed, N., Abou-Jabal, D., Kittu, P., Brinkmeier, M. L., Olsen, J., Sunny, D. A., Camper, S. A., Lovell-Badge, R., Rizzoti, K., & Ellsworth, B. S. (2026). NR3C1 is required for normal somatotrope differentiation and Foxo1 expression in pituitary. Endocrinology, 167(7). https://doi.org/10.1210/endocr/bqag060
Vancouver
Das P, Abubakar RA, Mojahed N, Abou-Jabal D, Kittu P, Brinkmeier ML, et al. NR3C1 is required for normal somatotrope differentiation and Foxo1 expression in pituitary. Endocrinology. 2026;167(7). doi:10.1210/endocr/bqag060
BibTeX
@article{Das2026,
author = {Das, Pratyusa and Abubakar, Ridwanullah A and Mojahed, Nooshin and Abou-Jabal, Dania and Kittu, Prisha and Brinkmeier, Michelle L and Olsen, Jessica and Sunny, Dale Ann and Camper, Sally A and Lovell-Badge, Robin and Rizzoti, Karine and Ellsworth, Buffy S},
title = {NR3C1 is required for normal somatotrope differentiation and Foxo1 expression in pituitary},
journal = {Endocrinology},
year = {2026},
volume = {167},
number = {7},
doi = {10.1210/endocr/bqag060}
}
EUVIMED